Magellan Health Inc logo

MGLN - Magellan Health Inc Share Price

$94.23 0.2  0.2%

Last Trade - 15/04/21

Mid Cap
Market Cap £1.77bn
Enterprise Value £1.36bn
Revenue £3.32bn
Position in Universe 2050th / 6851
Unlock MGLN Revenue
Relative Strength (%)
1m -3.17%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -1.26%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
4,597 4,837 5,839 4,958 4,566 4,578 4,680 5,017 -0.09%
-58.0 +165.6 +29.5 -78.8 -42.1 +559.6 -11.3 +33.7
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, MagellanHealth Inc revenues increased less than 1% to $4.58B. Netincome before extraordinary items decreased 68% to $4M.Revenues reflect Pharmacy Management segment increase of 5%to $2.64B, also reflect Healthcare segment decrease of 59%to $1.96B. Net income was partially offset by Healthcaresegment income decrease of 24% to $135.2M, Corporate &Other segment loss increase from $35.2M to $76.6M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for MGLN
Graphical History


MGLN Revenue Unlock MGLN Revenue

Net Income

MGLN Net Income Unlock MGLN Revenue

Normalised EPS

MGLN Normalised EPS Unlock MGLN Revenue

PE Ratio Range

MGLN PE Ratio Range Unlock MGLN Revenue

Dividend Yield Range

MGLN Dividend Yield Range Unlock MGLN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MGLN EPS Forecasts Unlock MGLN Revenue
Profile Summary

Magellan Health, Inc. is engaged in the healthcare management business. The Company provides managed care and pharmacy solutions for healthcare. The Company's segments include Healthcare, Pharmacy Management and Corporate. Its Healthcare includes carve-out management services for behavioral health, employee assistance plans (EAP) and other areas of specialty healthcare including diagnostic imaging, musculoskeletal management, cardiac and physical medicine. Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists of amounts not allocated to the Healthcare and Pharmacy Management segments. The Company provides services to health plans and other managed care organizations (MCOs), employers, labor unions, various military and governmental agencies and third party administrators (TPAs).

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated August 11, 1969
Public Since January 6, 2004
No. of Shareholders: 224
No. of Employees: 9,000
Sector Healthcare
Industry Healthcare Providers & Services
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 25,965,579
Free Float (0.0%)
Eligible for
MGLN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for MGLN
Upcoming Events for MGLN
Monday 10th May, 2021 Estimate
Q1 2021 Magellan Health Inc Earnings Release
Thursday 17th June, 2021 Estimate
Magellan Health Inc Annual Shareholders Meeting
Tuesday 27th July, 2021 Estimate
Q2 2021 Magellan Health Inc Earnings Release
Frequently Asked Questions for Magellan Health Inc
What is the Magellan Health Inc share price?

As of 15/04/21, shares in Magellan Health Inc are trading at $94.23, giving the company a market capitalisation of £1.77bn. This share price information is delayed by 15 minutes.

How has the Magellan Health Inc share price performed this year?

Shares in Magellan Health Inc are currently trading at $94.23 and the price has moved by 81.21% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Magellan Health Inc price has moved by 22.99% over the past year.

What are the analyst and broker recommendations for Magellan Health Inc?

Of the analysts with advisory recommendations for Magellan Health Inc, there are there are currently 0 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Magellan Health Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Magellan Health Inc next release its financial results?

Magellan Health Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Magellan Health Inc dividend yield?

Magellan Health Inc does not currently pay a dividend.

Does Magellan Health Inc pay a dividend?

Magellan Health Inc does not currently pay a dividend.

When does Magellan Health Inc next pay dividends?

Magellan Health Inc does not currently pay a dividend.

How do I buy Magellan Health Inc shares?

To buy shares in Magellan Health Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Magellan Health Inc?

Shares in Magellan Health Inc are currently trading at $94.23, giving the company a market capitalisation of £1.77bn.

Where are Magellan Health Inc shares listed? Where are Magellan Health Inc shares listed?

Here are the trading details for Magellan Health Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: MGLN
What kind of share is Magellan Health Inc?

Based on an overall assessment of its quality, value and momentum, Magellan Health Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Magellan Health Inc share price forecast 2021?

Shares in Magellan Health Inc are currently priced at $94.23. At that level they are trading at 0.24% premium to the analyst consensus target price of 0.00.

Analysts covering Magellan Health Inc currently have a consensus Earnings Per Share (EPS) forecast of 3 for the next financial year.

How can I tell whether the Magellan Health Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Magellan Health Inc. Over the past six months, the relative strength of its shares against the market has been 0.05%. At the current price of $94.23, shares in Magellan Health Inc are trading at 13.9% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Magellan Health Inc PE Ratio?

The Magellan Health Inc PE ratio based on its reported earnings over the past 12 months is 27.86. The shares are currently trading at $94.23.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Magellan Health Inc?

Magellan Health Inc's management team is headed by:

Caskie Lewis-Clapper - CHO
Steven Shulman - CHM
Mostafa Kamal - CEX
G. Scott MacKenzie - IND
Swati Abbott - IND
Peter Feld - IND
Kenneth Fasola - CEO
James Murray - PRE
David Haddock - GCN
Tim Lacy - OTH
Caroline Carney - OTH
Christopher Chen - DRC
Mural Josephson - DRC
David Bourdon - CFO
Who are the major shareholders of Magellan Health Inc?

Here are the top five shareholders of Magellan Health Inc based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 13.13% (3.41m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 9.16% (2.38m shares)
Starboard Value LP Hedge Fund
Percentage owned: 9.12% (2.37m shares)
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund
Percentage owned: 7.12% (1.85m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 5.91% (1.54m shares)
Similar to MGLN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.